Paul Perreault, CEO and managing director of CSL Limited, was the guest speaker at the March 12 Penn State Forum. IMAGE: PATRICK MANSELL

Heard on Campus: Paul Perreault at the Penn State Forum

Paul Perreault, chief executive officer and managing director of CSL Limited, the second largest biotherapeutics company in the world with more than 22,000 employees, presented “Innovation in Biotechnology: The Promise, The Potential, The Pitfalls” at the Penn State Forum on March 12 at The Nittany Lion Inn.

Partnership announced between Commonwealth Campuses and shared facilities

The Office of the Vice President for Research at Penn State has announced the launch of a new program to support increased usage of shared core facilities and services by faculty at the Commonwealth Campuses.

New Fermentation Facility Brings New Opportunities

With a generous gift from its namesake benefactor, the CSL Behring Fermentation Facility puts Penn State students a step ahead

Announcing major equipment acquisitions at the Huck Institutes

The Huck Institutes of the Life Sciences, in conjunction with the Office of the Vice President for Research and the Office of the Provost, are pleased to announce several major equipment acquisitions that will further strengthen the research capabilities of their Core Facilities at University Park.

Ancient gene family linked to the future of epileptic seizures

A potassium-channel gene belonging to an ancient gene family more than 542 million years old is opening new avenues in epilepsy research, and may one day allow researchers to develop more effective drugs with fewer side effects for the treatment of epileptic seizures.